UBE2M and hepatocellular carcinoma: In CPTAC database, only the patients with high protein levels of UBA3 or UBE2M conferred poorer overall survival than those with low expression in HCC patients (Log-rank test: UBA3, P=0.029; UBE2M, P=0.037); (Supplementary Figure S1B).